Publications

Search results

Journal Article (2)

  1. 2016
    Journal Article
    Bachmann, M.; Breitwieser, T.; Lipps, C.; Wirth, D.; Jordan, I.; Reichl, U.; Frensing, T.: Impaired antiviral response of adenovirus-transformed cell lines supports virus replication. Journal of General Virology 97 (2), pp. 293 - 298 (2016)
  2. Journal Article
    Frensing, T.; Kupke, S. Y.; Bachmann, M.; Fritzsche, S.; Gallo Ramirez, L. E.; Reichl, U.: Influenza virus intracellular replication dynamics, release kinetics, and particle morphology during propagation in MDCK cells. Applied Microbiology and Biotechnology 100 (16), pp. 7181 - 7192 (2016)

Conference Paper (2)

  1. 2018
    Conference Paper
    Duvigneau, S.; Dürr, R.; Laske, T.; Bachmann, M.; Dostert, M.; Reichl, U.; Kienle, A.: Mathematical modeling as a tool to improve influenza vaccine production processes. FOSBE 2018, Chicago, Illinois, USA, August 05, 2018 - August 08, 2018. IFAC-PapersOnLine 51 (19), pp. 1 - 4 (2018)
  2. 2016
    Conference Paper
    Dürr, R.; Duvigneau, S.; Laske, T.; Bachmann, M.; Kienle, A.: Analyzing the Impact of Heterogeneity in Genetically Engineered Cell Lines for Influenza Vaccine Production Using Population Balance Modeling. Foundations of Systems Biology in Engineering - FOSBE 2016 — Magdeburg, Germany, 9—12 October 2016, Magdeburg, Germany, October 09, 2016 - October 12, 2016. IFAC-PapersOnLine 49 (26), pp. 225 - 230 (2016)

Talk (2)

  1. 2017
    Talk
    Laske, T.; Bachmann, M.; Dostert, M.; Karlas, A.; Wirth, D.; Frensing, T.; Reichl, U.: Model-based characterization of influenza A virus production in genetically engineered cell lines elucidates changes in virus replication. 3rd Workshop on Virus Dynamics, Heidelberg, Germany (2017)
  2. 2016
    Talk
    Laske, T.; Bachmann, M.; Frensing, T.; Reichl, U.: Model-based analysis of influenza A virus replication in genetically modified cell lines elucidates virus-host cell interactions. 1st ESACT Frontiers Retreat, Lyon, France (2016)

Poster (8)

  1. 2018
    Poster
    Laske, T.; Bachmann, M.; Dostert, M.; Frensing, T.; Karlas, A.; Wirth, D.; Reichl, U.: Modeling reveals changes in key parameters of infuenza A virus replication in engineered cell lines. 11th Annual International Conference on Systems Biology of Human Diseases, Los Angeles, USA (2018)
  2. 2016
    Poster
    Dürr, R.; Duvigneau, S.; Laske, T.; Bachmann, M.; Kienle, A.: Analyzing the impact of heterogeneity in genetically engineered cell lines for influenza vaccine production using population balance modeling. 6th IFAC Conference on Foundations of Systems Biology in Engineering (FOSBE), Magdeburg, Germany (2016)
  3. Poster
    Laske, T.; Bachmann, M.; Frensing, T.; Reichl, U.: Model-based analysis of influenza A virus replication in genetically modified cell lines elucidates virus-host cell interactions. 17th International Conference on Systems Biology (ICSB), Barcelona, Spain (2016)
  4. 2015
    Poster
    Bachmann, M.; Breitwieser, T.; Lipps , C.; Wirth, D.; Jordan, I.; Rose, T.; Sandig, V.; Reichl, U.; Frensing, T.: Impaired antiviral response supports viral vaccine production in adenoviral transformed designer cell lines. 25th Annual Meeting of the Society for Virology, Bochum, Germany (2015)
  5. Poster
    Bachmann, M.; Breitwieser, T.; Lipps, C.; Wirth, D.; Jordan, I.; Rose, T.; Sandig, V.; Reichl, U.; Frensing, T.: Impaired antiviral response supports influenza vaccine production in adenoviral transformed designer cell lines. ESACT, Barcelona (2015)
  6. 2014
    Poster
    Bachmann, M.; Frensing, T.; Sandig, V.; Reichl, U.: Expression of adenoviral early-region E1A protein benefits cell culture-based influenza vaccine production. 4th International Influenza Meeting, Münster, Germany (2014)
  7. Poster
    Frensing, T.; Heldt, S.; Bachmann, M.; Genzel, Y.; Jordan, I.; Reichl, U.: Continuous influenza vaccine production. ProcessNet-Jahrestagung und 31. DECHEMA-Jahrestagung der Biotechnologen 2014, Aachen, Germany (2014)
  8. Poster
    Frensing, T.; Heldt, S.; Bachmann, M.; Genzel, Y.; Jordan, I.; Reichl, U.: CONTINUOUS INFLUENZA VACCINE PRODUCTION. Vaccine Technology 2014, Playa del Carmen, Mexico (2014)
 
loading content
Go to Editor View